Drugs / Lipid Emulsion
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT03792997 | Jan → Dec 2019 | infertility disorder | Benha University | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT03564574 | Sep 2015 → Dec 2016 | organophosphate poisoning | Post Graduate Institute of Medical Education and Research, Chandigarh | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT06052956 Background | Jul 2026 → Jun 2031 expected | abscess | University of Rochester | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT05006638 Comparator | Dec 2022 → Jun 2023 | poisoning | Aya Sabry Mohamed Mohamed | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | lipid emulsion | “lipid emulsion \& prednisolone \& LMWH” NCT03792997 ↗ |
| Route | Intravenous | “100 mL of 20% intravenous lipid emulsion” PMID 30307350 ↗ Oct 2018 |